However, wild-type and conditional animals were indistinguishable with respect to total, trabecular, or cortical bone mineral densities, or in trabecular bone volume, thickness, number, and separation in the secondary spongiosa
Pitolisant in PWS is currently advancing through late-stage development, with Phase III topline data readout expected in 2H 2026
It is not intended for human consumption, medical diagnosis, treatment, or prevention of any disease
Monitoring at 6 to 8 Weeks Recheck ALT, AST, fasting glucose, and IGF-1 six to eight weeks after starting therapy
7 , eabf1948 (2021)